ArticleCureus2026
Clinical Presentation, Risk Factors, and Clinical Outcomes of Patients Who Underwent Major Upper-Limb Amputation for Nontraumatic Indications: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Major upper-limb amputations are performed for various nontraumatic causes such as limb ischemia, malignancy, and infections. These procedures have significant psychosocial and functional impacts on patients, often leading to long-term disability and reduced quality of life. Understanding the interplay between the risk factors and disease progression is essential for improving preventive and therapeutic strategies. Limited data exist correlating clinical profile and surgical outcomes in nontraumatic major upper-limb amputations. This study aims to evaluate these factors in patients undergoing nontraumatic major upper-limb amputation at a tertiary care center. This study descriptively analyzes the demographic details, clinical presentation, risk factors, and surgical outcomes of patients undergoing major upper-limb amputation for nontraumatic indications. Methodology A retrospective observational study was conducted over a two-year period (August 2023 to August 2025) in the Department of General Surgery at a tertiary care center. In total, 23 patients who underwent major upper-limb amputation for nontraumatic causes were included. Data were collected from hospital records with respect to demographic details, comorbidities, Doppler and CT angiography findings, indications and level of amputation, and postoperative outcomes, including duration of hospital stay, revision amputation, surgical site infection, intensive care unit admission, readmission, and mortality. Results Among the 23 patients, 78.9% were middle-aged, and 69.6% were male. The left upper limb was involved in 73.9% of cases. Diabetes mellitus was present in 60.9% of patients, hypertension in 39.1%, and 65.2% were smokers. Anemia was observed in 69.5%, and hypoalbuminemia in 39%. Brachial artery involvement was noted in 30% of cases. Limb ischemia was the most common indication (78%), followed by necrotizing fasciitis (17.4%). Above-elbow amputation was performed in 91.3% of patients. Revision amputation was required in 8.6% of cases. Hospital readmission occurred in 4.3%, and one (4.3%) case of mortality was recorded. The mean hospital stay was 8.7 days. Conclusions Vascular insufficiency was noted to be the leading cause of nontraumatic major upper-limb amputation. While limited by a small sample size, these findings provide a descriptive profile with respect to nontraumatic major upper-limb amputations. Early diagnosis and aggressive management of vascular and infectious etiologies may improve limb salvage rates and reduce morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.